Related Experiment Video
Updated: Jun 27, 2026

Mouse Model of Acute to Chronic Kidney Disease Transition Induced by Renal Ischemia/Reperfusion Injury
Published on: February 10, 2026
Anemia and risk of hospitalization in pediatric chronic kidney disease
Amy O Staples1, Craig S Wong, Jodi M Smith
1Division of Pediatric Nephrology, University of New Mexico, Albuquerque, NM 87131, USA. astaples@salud.unm.edu
Insights
Anemia prevalence increases with chronic kidney disease (CKD) stage in children. Anemic children with predialysis CKD face a higher risk of hospitalization, underscoring the importance of monitoring anemia in this population.
Area of Science:
- Pediatric Nephrology
- Hematology
- Chronic Kidney Disease Research
Background:
- Anemia is a known complication of chronic kidney disease (CKD).
- The prevalence and impact of anemia across pediatric CKD stages remain unclear.
- Understanding anemia's role in pediatric CKD morbidity is crucial.
Purpose of the Study:
- To determine the prevalence of anemia in pediatric patients across different stages of chronic kidney disease (CKD).
- To investigate the association between anemia and hospitalization risk in children with predialysis CKD.
Main Methods:
- Analysis of 2,779 pediatric patients (ages 2+) with CKD stages II-V from the North American Pediatric Renal Trials and Collaborative Studies database.
- Descriptive statistics and logistic regression modeling were used.
- Anemia defined as hematocrit < 33%.
Main Results:
- Anemia prevalence rose from 18.5% in CKD stage II to 68% in CKD stage V (predialysis).
- Anemic children showed a 55% increased likelihood of hospitalization compared to non-anemic children (OR 1.55).
- Similar associations were observed with hematocrit cutoffs of 36% and 39%.
Conclusions:
- Anemia prevalence escalates with CKD stage in pediatric predialysis patients.
- Anemia is significantly linked to increased hospitalization risk in this population.
- Further research on anemia correction's impact on hospitalization is warranted.
Background And Objectives:
Anemia is a well known complication of chronic kidney disease (CKD); however, the prevalence of anemia within CKD stages in the pediatric population has not been established. Additionally, the associated morbidity of anemia in the pediatric CKD population has not been elucidated.
Design, Setting, Participants, & Measurements:
2,779 patients ages 2 yr and older in the North American Pediatric Renal Trials and Collaborative Studies database with CKD stage II to V (excluding dialysis or previous transplant patients) were identified. Descriptive statistics and multivariate modeling using logistic regression was performed to determine the prevalence of anemia and to evaluate the correlation between baseline anemia and hospitalization.
Results:
The prevalence of anemia (hematocrit < 33%) increased from 18.5% in CKD stage II to 68% in CKD stage V (predialysis). Anemic children were 55% more likely to be hospitalized when compared with nonanemic children (odds ratio 1.55; 95% confidence interval 1.23 to 1.94). Similar results were obtained using hematocrit cutoffs of 36 and 39%.
Conclusions:
In this pediatric predialysis CKD population, anemia increases with increasing CKD stage and is significantly associated with hospitalization risk. Hematocrit levels above 36 and 39% were not associated with increased risk of hospitalization. Further examination into the effect of correcting anemia on hospitalization rates may provide additional useful information.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury V: Interprofessional Care